TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma.

Dan T Vogl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.